Skip to main content

MedPath Trial Home

Organizations News Research

Data Sources:ClinicalTrials.govEU CTRFDAEMANMPATGAHealth CanadaWHO ICTRP

MedPath Trial Home

Search trials. Track pipelines. Understand approvals. With AI-powered intelligence for clinical research.

Product

Clinical Trials
Drug Intelligence
Global Approvals
AI Research
Pricing

Resources

FAQ
Search

Company

News
About
Contact

Legal

Privacy Policy
Terms of Service

Disclaimer: This website provides information retrieval and data analysis services. The content does not constitute medical advice. Eligibility assessments are for reference only and should not replace consultation with qualified healthcare professionals. Data is sourced from public registries and regulatory agencies; MedPath does not guarantee completeness or accuracy. Always verify information with primary sources.

© 2026 MedPath Trial. All rights reserved.

We value your privacy

We use cookies to analyze site traffic and improve your experience. See our Privacy Policy.

Nasehaler - Philippines FDA Drug Approval Details

Approvals/Philippines FDA/Nasehaler

Approved

STANDARD

Nasehaler

Cipla Limited, Indore Sez (Unit III)🇵🇭 Food and Drug Administration - Philippines

Approval Date: Jul 14, 2025
Approval ID: 5c0be08e17d81b05
Company: Cipla Limited, Indore Sez (Unit III)
Type: Standard

Approval Details

Approval Id: 5c0be08e17d81b05
Drug Approval Philippines Name: Nasehaler
Product Name: Nasehaler
Registration Number: DRP-13925
Brand Name: Nasehaler
Generic Name: Mometasone furoate (as monohydrate)
Dosage Form: Nasal Spray Suspension
Dosage Strength: 50 mcg per actuation (0.05% w/w)
Manufacturer: Cipla Limited, Indore Sez (Unit III)
Importer: RV Group Phil. Branch
Distributor: RV Group Phil. Branch
Issuance Date: 27 May 2024
Expiry Date: 18 May 2028
Pharmacologic Category: Corticosteroid
Classification: Prescription Drug (Rx)

Active Ingredients

Approved

Quick Info

Agency

Philippines FDA

Country

🇵🇭

Approval Date

Jul 14, 2025

Approval ID

5c0be08e17d81b05

Type

Standard

Back to Philippines FDA Approvals